PHE News

Precision's Strong Presence at ISPOR 2016

Precision Health Economics (PHE) researchers and scientific advisors will once again have a very strong presence at ISPOR’s 21st Annual International Meeting in Washington DC from May 21-25, 2016. PHE experts will be teaching 2 short courses, moderating and speaking at 3 issue panels, presenting 13 posters, and participating in the National Pharmaceutical Council (NPC) sponsored educational symposium.

READ MORE

Precision's Chandra and Shafrin Discuss Value Frameworks in JAMA

Precision Health Economics' Amitabh Chandra and Jason Shafrin, along with co-author Ravider Dhawan, examine the utility of cancer value frameworks in the latest edition of the Journal of the American Medical Association (JAMA).

READ MORE

HEOR Leader Neumann Joins PHE as Advisor

Precision Health Economics (PHE), a global leader in health economic research, policy, and analytics, announced today that Peter Neumann, ScD has joined PHE in the role of principal scientific advisor.

READ MORE

Precision Researchers Prominently Featured in AJMC's Special Issue on HCV

Precision Health Economics authors are prominently featured in the May 2016, Special Issue on the Hepatitis C virus, just released by The American Journal of Managed Care.

READ MORE

Precision's Sharma in The Lancet: Liberating Data to Combat NCD's

In the latest edition of The Lancet Daibetes & Endocrinology, Precision's Abhishek Sharma co-authors an article focusing on the challenges of collecting, analysing, and using data related to non-communicable diseases (NCD's).

READ MORE
 
  • Academic Insights at

    the Speed of Business

     
  • Intellectual Integrity

    Led by professors at elite research universities, we bring intellectual integrity, academic rigor, and a creative approach to the most challenging problems in heath care.

     
  • Real World Impact

    PHE recommendations have defined and changed national and international payment policies.

     
  • Unparalleled Influence

    We frequently appear in top-tier publications and media outlets-- our work reaches top decision makers and influences outcomes.

     
  • Evidence Generation and

    Commercial Excellence

    As part of Precision for Value, our academic approach to research can be linked with a tailored, commercial approach that demonstrates the value of innovative medications.

     
  • Academic Insights at

    the Speed of Business